The shingles vaccine (Shingrix) is highly effective, but it does come with real downsides, mostly in the form of temporary side effects that can be surprisingly intense. Serious risks exist but are extremely rare. Here’s what to weigh before getting vaccinated.
Side Effects Are Common and Can Be Rough
Shingrix has a reputation for causing more noticeable reactions than most adult vaccines. In reports to the CDC’s adverse event tracking system, the most frequent complaints were injection site pain (22.5%), redness at the injection site (20.1%), fatigue (16%), injection site swelling (13.4%), and muscle pain (12.1%). These numbers likely undercount the true rate, since not everyone reports mild reactions. Clinical trials before approval showed even higher rates of these symptoms.
The CDC notes that common side effects “may affect your ability to do daily activities” but should resolve on their own within a few days. That’s a notable caveat for a vaccine. Some people feel wiped out for a day or two after their shot, enough to miss work or cancel plans. If you’re scheduling your doses, picking a day where you can take it easy the following day is a practical move.
Why Shingrix Hits Harder Than Other Vaccines
The intensity of these reactions comes down to the vaccine’s design. Shingrix contains a powerful ingredient called an adjuvant that deliberately kicks the immune system into a stronger response than the viral protein alone would trigger. This adjuvant activates parts of your innate immune system through multiple pathways, including triggering an inflammatory response. In preclinical testing, the vaccine caused a measurable spike in a blood marker of systemic inflammation, which correlates with the fatigue, muscle aches, and general malaise that people experience.
That aggressive immune activation is the same reason Shingrix works so well. It’s a trade-off: the adjuvant produces stronger, longer-lasting protection, but it also makes the short-term experience more uncomfortable than a typical flu shot.
The Second Dose Can Be Worse
You need two doses of Shingrix, spaced two to six months apart. Studies suggest that symptoms tend to be more intense after the second dose, though that’s not universal. Your reaction to the first dose doesn’t reliably predict how you’ll feel after the second. Some people breeze through the first and get hit hard by the second, while others have the opposite experience. Either way, skipping the second dose significantly reduces the vaccine’s long-term effectiveness, so it’s worth pushing through.
A Small but Real Risk of Guillain-Barré Syndrome
The most serious known risk is a slight increase in the chance of developing Guillain-Barré syndrome (GBS), a condition where the immune system attacks the nerves, causing weakness and sometimes temporary paralysis. The FDA now requires this warning on the vaccine’s prescribing information.
Post-licensure surveillance found roughly 3 extra cases of GBS per million doses in adults 65 and older during the 42 days following vaccination. When researchers looked specifically at the first dose, the rate was about 6 extra cases per million. No increased risk was found after the second dose. To put that in perspective, your baseline risk of GBS from any cause in a given year is about 10 to 20 per million. The vaccine adds a small, temporary bump to that already low number.
Notably, the FDA did not identify any increased GBS risk in the clinical trials conducted before Shingrix was approved in 2017. The signal only appeared after millions of real-world doses were tracked, which speaks to how rare it is.
Who Should Not Get the Vaccine
Very few people have a true contraindication. The only absolute reason to avoid Shingrix is a known severe allergic reaction to one of its components or a previous dose. Beyond that, the CDC lists several precautions rather than hard stops:
- Active shingles outbreak: Vaccination should wait until the episode resolves and symptoms clear.
- Moderate or severe acute illness: It’s best to wait until you recover, though minor illness isn’t a reason to delay.
- Pregnancy: No safety data exists for pregnant or breastfeeding women. The recommendation is to wait until after delivery and lactation.
How Long Protection Lasts
One practical downside worth knowing: protection doesn’t last forever. In adults 70 and older with healthy immune systems, Shingrix immunity remained high for at least 7 years after vaccination. Data beyond that point is still being collected, since the vaccine was only approved in 2017. There’s a chance a booster dose will eventually be recommended, though none is currently part of the schedule.
Cost Is Rarely an Issue Now
Cost used to be a legitimate barrier. Without insurance, Shingrix runs over $300 for the two-dose series. But Medicare Part D now covers the shingles vaccine with no copayment and no deductible, since it falls under the recommended adult vaccine benefit. Most private insurance plans cover it as well for adults 50 and older. If cost has been holding you off, it’s worth checking your current coverage, as the landscape has shifted significantly in recent years.
Weighing the Downsides Against Shingles Itself
The downsides of Shingrix are real: a couple of rough days after each shot, a very small chance of a serious neurological complication, and the inconvenience of needing two doses. But shingles itself causes a painful blistering rash that typically lasts two to four weeks, and about 10 to 18 percent of people who get shingles develop postherpetic neuralgia, a nerve pain condition that can persist for months or years. The risk of shingles climbs sharply after age 50, and roughly one in three people will develop it in their lifetime.
Shingrix is over 90 percent effective at preventing shingles in the first several years after vaccination, and it significantly reduces the risk of postherpetic neuralgia. For most adults over 50, the math favors vaccination. The side effects are temporary and self-limiting. The protection against a painful, sometimes debilitating disease lasts years.